Protection of Wistar Furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase

Journal of the American Society of Nephrology

Volumn 14, Issue 10, 2003, Pages 2526-2533

  Erdely, Aaron ^a,d   Wagner, Laszlo ^a,b   Muller, Veronica ^a,c   Szabo, Attila ^a,c   Baylis, Chris ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PÉCS   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SPECIFICITY; KIDNEY ABLATION; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY INFARCTION; KIDNEY INJURY; KIDNEY MASS; MALE; NEPHRON; NERVE CELL; NONHUMAN; OXIDATION KINETICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RAT; STRAIN DIFFERENCE;

EID: 0141678277     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000086476.48686.7D     Document Type: Article

References (29)

1. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A, Corna D, Zoja C, Cavallotti D, Remuzzi G: Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 52: 171-181, 1997
2. Ashab I, Peer G, Blum M, Wollman Y, Chemihovsky T, Hassner A, Schwartz D, Cabili S, Silverberg D, Iaina A: Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 47: 1515-1521, 1995
3. Schmidt RJ, Baylis C: Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58: 1261-1266, 2000
4. Schmidt RJ, Yokota S, Tracy TS, Sorkin MI, Baylis C: Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis. Am J Physiol 276: F794-F797, 1999
5. Schmidt R, Domico J, Samsell L, Yokota S, Tracy T, Sorkin M, Engels K, Baylis C: Indices of activity of the nitric oxide system in patients on hemodialysis. Am J Kidney Dis 34: 228-234, 1999
6. Zatz R, Baylis C: Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998
7. Moskowitz DW, Schneider AN, Lane PH, Schmitz PG, Gillespie KN: Effect of epidermal growth factor in the rat 5/6 renal ablation model. J Am Soc Nephrol 3: 1113-1118, 1992
8. Katoh T, Takahashi K, Klahr S, Reyes AA, Badr KF: Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol 4: 1690-1694, 1994
9. Fitzgibbon WR, Greene EL, Grewal JS, Hutchison FN, Self SE, Latten SY, Ullian ME: Resistance to remnant nephropathy in the Wistar-Furth rat. J Am Soc Nephrol 10: 814-821, 1999
10. NOxV) do not predict renal vascular NO production. Kidney Int 48: 1272-1277, 1995
11. Yang YD: Simultaneous determination of creatine, uric acid, creatinine and hippuric acid in urine by high performance liquid chromatography. Biomed Chromatogr 12: 47-49, 1998
12. Xiao S, Erdely A, Wagner L, Baylis C: Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function. Am J Physiol 49: F996-F1000, 2001
13. Lau KS, Grange RW, Chang WJ, Kamm KE, Sarelius I, Stull JT: Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett 431: 71-74, 1998
14. Damadian RV, Shwayri E, Bricker NS: On the existence of non-urine forming nephrons in the diseased kidney of the dog. J Lab Clin Med 65: 26-39, 1965
15. Vaziri ND, Ni Z, Wang XQ, Oveisi F, Zhou XJ: Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH. Am J Physiol 274: F642-F649, 1998
16. Roczniak A, Fryer JN, Levine DZ, Burns KD: Downregulation of neuronal nitric oxide synthase in the rat remnant kidney. J Am Soc Nephrol 10: 704-713, 1999
17. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R: Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39: 135-141, 2002
18. Fujihara CK, Mattar AL, Vieira JM Jr, Malheiros DM, Noronha Ide L, Goncalves AR, De Nucci G, Zatz R: Evidence for the existence of two distinct functions for the inducible NO synthase in the rat kidney: Effect of aminoguanidine in rats with 5/6 ablation. J Am Soc Nephrol 13: 2278-2287, 2002
19. Kang DH, Nakagawa T, Feng L, Johnson RJ: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 161: 239-248, 2002
20. Szabo A, Wagner L, Erdely A, Lau K, Baylis C: Renal neuronal nitric oxide synthase protein expression as a marker of renal function. Kidney Int 2003, in press
21. Wagner L, Riggleman A, Erdely A, Couser W, Baylis C: Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int 62: 532-536, 2002
22. Deleted in proof
23. Erdely A, Greenfeld Z, Wagner L, Baylis C: Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. Kidney Int 63: 1021-1026, 2003
24. Hill C, Lateef AM, Engels K, Samsell L, Baylis C: Basal and stimulated nitric oxide in control of kidney function in the aging rat. Am J Physiol 272: R1747-R1753, 1997
25. Anderson S, Brenner BM: Therapeutic implications of converting-enzyme inhibitors in renal disease. Am J Kidney Dis 1[Suppl 1]: 81-87, 1987
26. Ullian ME, Islam MM, Robinson CJ, Fitzgibbon WR, Tobin ET, Paul RV: Resistance to mineralocorticoids in Wistar-Furth rats. Am J Physiol 272: H1454-H1461, 1997
27. Hostetter TH, Rosenberg NM, Ibrahim HN, Jukrievicius I: Aldosterone in renal disease. Curr Opin Nephrol Hypertens 10: 105-110, 2001
28. Brenner BM, Mackenzie HS: Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 63: S124-S127, 1997 A, Baylis C: J Am Soc Nephrol 12: 812A, 2001
29. Brenner BM, Mackenzie HS: Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 63: S124-S127, 1997 A, Baylis C: J Am Soc Nephrol 12: 812A, 2001